Legal Representation
Attorney
Karl M. Zielaznicki, Esq.
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 20, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 20, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 20, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 10, 2025 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Sep 10, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Sep 9, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 9, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 9, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 8, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 8, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Sep 8, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 8, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 8, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 8, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 8, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 8, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 27, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 20, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Avenanthramides and oat beta glucan for use as ingredients in cosmetics; active natural chemical ingredients in the nature of avenanthramides and oat beta glucan for use in the manufacture of nutritional supplements, cosmeceuticals, nutraceuticals, and pharmaceuticals
Class 003
Non-medicated toiletry preparations; personal care products, namely, body lotion, shower gel, body polish, body and foot scrub and non-medicated skin creams; animal and pet care products, namely, non-medicated grooming preparations in the nature of shampoos for animals, moisturizers for animals, and conditioners for animals, all containing humectants; oat based cosmetic products for animals, namely, non-medicated grooming preparations in the nature of animal skin creams and balms; cosmetics; cosmetics, namely, shampoo, anti-irritant creams, moisturizing creams, skin creams, skin balms, oat based cosmetic products, namely, skin moisturizing products in the form of creams, gels and lotions; sunblock and sunscreen lotions, eye shadow and blush powders, lip sticks and balms
Class 005
Nutritional supplements, medicated cosmeceuticals, namely, cosmetics for the treatment of skin conditions; nutraceuticals for use as dietary supplements; pharmaceuticals for reducing cholesterol, blood glucose and for the treatment of inflammatory bowel syndrome, atherosclerosis, hypoparathyroidism, autoimmune diseases, and inflammation; medical preparations, namely, orally administered macimorelin for diagnosis of growth hormone deficiency in children and adults; dietetic food and beverages adapted for medical or veterinary use; dietary and nutritional supplements for improving nail strength, supporting healthy skin and maintaining shiny hair; dietary and nutritional supplements for general health and wellbeing; avenanthramides for supplement purposes; avenanthramides for pharmaceutical purposes; nutraceuticals for use as dietary supplements containing avenanthramides; medicated cosmeceuticals, namely, medicated skincare preparations containing avenanthramides; oat beta glucan for supplement purposes; oat beta glucan for pharmaceutical purposes; nutraceuticals for use as dietary supplements containing oat beta glucan; medicated cosmeceuticals, namely, medicated skincare preparations containing oat beta glucan; veterinary medicine products, namely, natural, non-antibiotic, anti-microbial, preparations for the treatment of mastitis in animals; natural saponin-based preparations acting on the immune systems of animals and humans to help fight infection and disease; pharmaceutical medicine products for human and animal use, namely pharmaceutical preparations in the area of immunology and bioengineering, oat based preparations for use in the diagnosis and monitoring of diabetes, pharmaceutical preparations in cream, lotion and liquid gel forms for the moisturizing treatment of lips and skin and the anti-bacterial treatment of cold sores, herpes sores, acne and skin diseases, pharmaceutical anti-irritant and moisturizing cream, immune system stimulants; pharmaceutical preparations for skin care, namely medicated sunscreens, medicated skin creams, gels, balms and lotions, medicated shampoo, medicated lip balm; health care products, namely anti-irritant and moisturizing cream, for dermatological use, medicated shampoo; animal feed additives for use as nutritional supplements; nutritional supplements, namely, oat based supplements; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceuticals preparation for immunology and inflammation based diseases; pharmaceutical preparations used for the treatment of urological diseases; pharmaceutical preparations used for the treatment of hormonal disorders; synthetic peptides-containing pharmaceutical preparations used for hormonal treatments; pharmaceutical preparations used for the treatment of endocrine diseases; pharmaceutical preparations used for the treatment of haematological diseases; pharmaceutical preparations used for the treatment of age-related diseases; pharmaceutical preparations used for the treatment of ophthalmological disorders; pharmaceutical preparations used for the treatment of reproductive system disorders; pharmaceutical preparations used for the treatment of endometriosis; pharmaceutical preparations used for the treatment of uterine myoma; pharmaceutical preparations used for the treatment of benign prostatic hyperplasia; pharmaceutical preparations used for the treatment of tropical diseases; pharmaceutical preparations used for the treatment of infectious disease; pharmaceutical preparations used for the treatment of leishmaniasis; pharmaceutical preparations used for the treatment of obesity; pharmaceutical preparations used for the treatment of diabetes and disorders related to diabetes; pharmaceutical preparations based on LHRH antagonists platform for the treatment of hormonal disorders; pharmaceutical preparations used to stimulate growth hormone secretagogue for the diagnosis of growth hormone deficiency; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of respiratory diseases; pharmaceutical preparations for the treatment of gastrointestinal diseases; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, comprising human growth hormone secretagogues, ghrelin receptor agonists, ghrelin receptor antagonists, ghrelin mimetics, human growth hormone analogues, human growth hormone fusion proteins, human growth hormone releasing hormone analogues, auto immune modulating proteins, therapeutic antibodies, small molecule kinase inhibitors, phospholipids for the treatment of neurological disorders; pharmaceutical preparations for the treatment of nasopharyngeal disorders; antibiotics; antibacterial pharmaceuticals, antibacterial handwash, antibacterial spray, antibacterial cleaners, antibacterial soap, antibacterial detergents, antibacterial hand lotions, fungicidal preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of rheumatoid diseases; pharmaceutical preparations for contraceptives and women's health; analgesic preparations, comprising small molecule kinase inhibitors, phospholipids, and therapeutic antibodies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for palliative treatments; pharmaceutical preparations for the treatment of addictions; pharmaceutical formulations for the treatment of paediatric indications; medical preparations, namely, medicinal oils, other than essential oils; medicated toiletry preparations
Class 030
Bread; flour; preparations made from cereals, namely, cereals crackers, dried cereal flakes, grain-based chips, grain-based snack foods, granola-based cereals, oat bran cereals, ready-to-eat cereals, breakfast cereals, cereal bars, cereal based energy bars, cereal based snack food, cereal flour; snack foods based on yeast extracts; yeast based snack foods; cereal based snack foods containing yeast beta glucan; yeast beta glucan for supplement purposes; dietary fiber to aid digestion oat based food products, namely, oat bran, oat flour, oat starch, oat beta glucan, and oat noodles
Class 032
Non-alcoholic beverages, namely isotonic non-alcoholic drinks, sports drinks, energy drinks, protein-enriched sports beverages; preparations for making non-alcoholic beverage, namely, concentrates, syrups or powders used in the preparation of isotonic sports drinks, energy drinks and sports beverages, and mixes for making sports drinks; beverages, namely, non alcoholic fibre health beverages for human and animal use
Classification
International Classes
001
003
005
030
032
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIOPHARMA